training – Trio Medicines

This author has not yet filled in any details.
So far training has created 1 blog entries.

The CCK(2) receptor antagonist, YF476, inhibits Mastomys ECL cell hyperplasia and gastric carcinoid tumor development.

training2019-03-26T13:22:08+00:00GNETs, Netazepide|